T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
Open Access
Abstract
In chronic viral hepatitis and in hepatocarcinoma (HCC), antigen-specific T cells are deeply exhausted, and evidence of dysfunction has also been observed for NK cells, which can play a pathogenetic role, exerting a regulatory activity on adaptive immune responsesKeywords
This publication has 10 references indexed in Scilit:
- Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and CCells, 2021
- Personalized Armored TCR-Redirected T Cell Therapy for Liver/Organ Transplant with Recurrent CancerCells, 2021
- Prospects and Challenges for T Cell-Based Therapies of HCCCells, 2021
- Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular CarcinomaCells, 2021
- Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular CarcinomaCells, 2021
- Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic ApproachesCells, 2021
- CD4+ T Cells in Chronic Hepatitis B and T Cell-Directed ImmunotherapyCells, 2021
- Adaptive subsets limit the anti-tumoral NK-cell activity in Hepatocellular CarcinomabioRxiv, 2021
- Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular CarcinomaCells, 2021
- Gamma-Chain Receptor Cytokines & PD-1 Manipulation to Restore HCV-Specific CD8+ T Cell Response during Chronic Hepatitis CCells, 2021